# Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-study-of-gefitinib-versus-erlotinib-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Seung Tae Kim,Ji Eun Uhm,Jeeyun Lee,Jong‐Mu Sun,Insuk Sohn,Seon Woo Kim,Sin‐Ho Jung,Yeon Hee Park,Jin Seok Ahn,Keunchil Park,Myung‐Ju Ahn |
| Citations | 98 |
| DOI | 10.1016/j.lungcan.2011.05.022 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2040181388 |
| PMID | 21684626 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Jong‐Mu Sun](https://scholariq.org/researchers/jong-mu-sun/)
- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn-2/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.